WallStreetZenWallStreetZen

NASDAQ: VIR
Vir Biotechnology Inc Stock Ownership - Who owns Vir Biotechnology?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Vir Biotechnology Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Vicki L. SatoDirector2026-05-0122,000$10.05
$221.03kSell
Backer Marianne DePresident and CEO2026-04-0672,559$9.16
$664.35kSell
Vicki L. SatoDirector2026-04-0122,000$9.07
$199.61kSell
Brent SabatiniSVP Chief Accounting Officer2026-03-237,711$9.12
$70.32kSell
Vicki L. SatoDirector2026-03-02200$9.98
$2.00kSell
Vicki L. SatoDirector2026-03-0221,800$9.50
$207.19kSell
Mark EisnerEVP and Chief Medical Officer2026-02-251,889$9.82
$18.55kSell
Verneuil Vanina DeEVP General Counsel Corp Sec2026-02-2513,700$9.82
$134.53kSell
Vicki L. SatoDirector2026-02-2442,377$1.49
$62.93kBuy
Backer Marianne DeChief Executive Officer2026-02-2414,762$9.53
$140.73kSell

1 of 6

VIR insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when VIR insiders and whales buy or sell their stock.

VIR Shareholders

What type of owners hold Vir Biotechnology Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Alaska Permanent Fund Corp11.95%16,666,668$166.83MInsider
Blackrock Inc11.70%16,330,103$163.46MInstitution
Svf Endurance Cayman Ltd9.84%13,728,924$137.43MInsider
Sb Investment Advisers Uk Ltd9.40%13,116,977$131.30MInstitution
Arch Venture Management LLC9.26%12,916,663$129.30MInstitution
Vanguard Group Inc8.99%12,548,944$125.61MInstitution
Gsk PLC6.13%8,550,954$85.60MInstitution
State Street Corp4.47%6,229,555$62.36MInstitution
Temasek Holdings Private Ltd3.94%5,499,999$55.05MInsider
Dhabi Investment Authority Abu2.63%3,666,666$36.70MInsider

1 of 3

VIR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
VIR69.12%30.88%Net SellingNet Selling
QURE89.72%10.28%Net SellingNet Selling
WVE78.30%21.70%Net BuyingNet Buying
GHRS75.07%24.19%
FTRE99.43%0.57%Net BuyingNet Selling
View Top Biotech Stocks

Vir Biotechnology Stock Ownership FAQ

Who owns Vir Biotechnology?

Vir Biotechnology (NASDAQ: VIR) is owned by 83.01% institutional shareholders, 37.08% Vir Biotechnology insiders, and 0.00% retail investors. Alaska Permanent Fund Corp is the largest individual Vir Biotechnology shareholder, owning 16.67M shares representing 11.95% of the company. Alaska Permanent Fund Corp's Vir Biotechnology shares are currently valued at $171.50M.

If you're new to stock investing, here's how to buy Vir Biotechnology stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.